Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues
Open Access
- 1 January 2016
- journal article
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 19 (2) , 148-155
Abstract
Damavandi Z, et al. J Breast Cancer. 2016 Jun;19(2):148-155. http://dx.doi.org/10.4048/jbc.2016.19.2.148Keywords
This publication has 30 references indexed in Scilit:
- MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heartAGE, 2012
- Non-Coding RNAs as Regulators of Mammary Development and Breast CancerJournal of Mammary Gland Biology and Neoplasia, 2012
- miR-22 represses cancer progression by inducing cellular senescenceJournal of Cell Biology, 2011
- miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressorBiochemical and Biophysical Research Communications, 2011
- microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicityBritish Journal of Cancer, 2010
- MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesisNature Medicine, 2010
- miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNAMolecular and Cellular Biology, 2009
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- A role for microRNAs in maintenance of mouse mammary epithelial progenitor cellsGenes & Development, 2007
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004